Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,197,428
-$176,773,488 QoQ
Shares Held
98,109
-90.9% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#115
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. BIIB ranks #14 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,197,428 | 98,109 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $197,970,916 | 1,079,861 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $187,537,759 | 1,065,616 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $149,455,694 | 1,066,931 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $134,985,513 | 1,074,811 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $146,914,434 | 1,073,622 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $163,083,063 | 1,066,460 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $19,177,948 | 98,937 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $213,914,454 | 922,761 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $374,622,623 | 1,737,340 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $367,762,888 | 1,421,196 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $305,725,217 | 1,189,546 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $272,218,895 | 955,657 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $225,309,394 | 810,378 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $218,090,561 | 787,558 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $245,102,262 | 917,986 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $193,709,349 | 949,835 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $197,517,106 | 937,878 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $191,679,045 | 798,929 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $181,134,823 | 640,075 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $206,566,329 | 596,547 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $174,576,309 | 624,044 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $126,549,524 | 516,824 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $123,519,377 | 435,418 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $103,358,577 | 386,315 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $110,378,970 | 348,881 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||